Elixinol Global Health Care
Biotech Cannabis Healthcare Pharmaceuticals

$0.013 0.001 (8.33%)

High $0.01	Low $0.01	Trades 23	Turnover $14,166	Volume 1,163,758
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code EXL	Name Elixinol Wellness Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date N/A	Fiscal Year December	Type Common Stock
Shares Outstanding 413,987,731	Shares Floated 329,563,213	Held by Insiders 33.058%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Ms. Natalie Butler	CEO & Executive Director
Mr. Adam Dimitropoulos	Chief Financial Officer
Mr. Mitchell Costin	Operations Director
Glen Zurcher	Account Director of Investor Relations Department
Mr. Peter Gibson	General Manager of Sales
Ms. Mariia Skorikova	Joint Company Secretary
Mr. Tony Di Pietro	Joint Company Secretary

EXL Historic Dividends

Date	Amount
We found no dividends on record for EXL.

End of Day Prices

Date	Close	Volume	Change
31-Jul	$0.01	90,000	+0.00 (16.67%)
30-Jul	$0.01	14,937	0.00 (14.29%)
29-Jul	$0.01	0	0.00 (0.00%)
28-Jul	$0.01	214,285	0.00 (0.00%)
27-Jul	$0.01	0	0.00 (0.00%)
24-Jul	$0.01	100,000	+0.00 (16.67%)
23-Jul	$0.01	1,015,332	0.00 (0.00%)
22-Jul	$0.01	0	0.00 (0.00%)
21-Jul	$0.01	1,077,957	0.00 (0.00%)
20-Jul	$0.01	100,000	0.00 (0.00%)
17-Jul	$0.01	1,780	-0.01 (53.85%)
18-Sep	$0.01	35,719	0.00 (23.53%)
12-Sep	$0.02	5,142	0.00 (5.56%)
11-Sep	$0.02	510,800	+0.00 (5.88%)
05-Sep	$0.02	0	0.00 (0.00%)
3 up, 4 down, and 8 flat days

Market Cap (31-Jul) $2,897,914	EBITDA -	PE 125.00	Book Value $0.02
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.02	Profit Margin N/A
Operating Margin -23.26%	ROA 18.37%	ROE 62.94%	Revenue (FY) $15,500,000
Revenue per Share $0.06	Gross Profit (FY) $5,713,000	Q' YOY Revenue Growth 4.3%	Q' YOY Earnings Growth -

Elixinol Global Health Care
Biotech Cannabis Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

EXL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Elixinol Global Health Care Biotech Cannabis Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

EXL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Elixinol Global Health Care
Biotech Cannabis Healthcare Pharmaceuticals